The COOH terminus of Rho-kinase negatively regulates rho-kinase activity - PubMed (original) (raw)
. 1999 Nov 5;274(45):32418-24.
doi: 10.1074/jbc.274.45.32418.
Affiliations
- PMID: 10542285
- DOI: 10.1074/jbc.274.45.32418
Free article
The COOH terminus of Rho-kinase negatively regulates rho-kinase activity
M Amano et al. J Biol Chem. 1999.
Free article
Abstract
Rho-kinase is implicated in the phosphorylation of myosin light chain downstream of Rho, which is thought to induce smooth muscle contraction and stress fiber formation in non-muscle cells. Here, we examined the mode of action of inhibitors of Rho-kinase. The chemical compounds such as HA1077 and Y-32885 inhibited not only the Rho-kinase activity but also the activity of protein kinase N, one of the targets of Rho, but had less of an effect on the activity of myotonic dystrophy kinase-related Cdc42-binding kinase beta (MRCKbeta). The COOH-terminal portion of Rho-kinase containing Rho-binding (RB) and pleckstrin homology (PH) domains (RB/PH (TT)), in which point mutations were introduced to abolish the Rho binding activity, interacted with Rho-kinase and thereby inhibited the Rho-kinase activity, whereas RB/PH (TT) had no effect on the activity of protein kinase N or MRCKbeta, suggesting that the COOH-terminal region of Rho-kinase is a possible negative regulatory region of Rho-kinase. The expression of RB/PH (TT) specifically blocked the stress fiber and focal adhesion formation induced by the active form of Rho or Rho-kinase in NIH 3T3 cells, but not that induced by the active form of MRCKbeta or myosin light chain. Thus, RB/PH (TT) appears to specifically inhibit Rho-kinase in vivo.
Similar articles
- Rho kinase mediates serum-induced contraction in fibroblast fibers independent of myosin LC20 phosphorylation.
Nobe H, Nobe K, Fazal F, De Lanerolle P, Paul RJ. Nobe H, et al. Am J Physiol Cell Physiol. 2003 Mar;284(3):C599-606. doi: 10.1152/ajpcell.00188.2002. Epub 2002 Oct 3. Am J Physiol Cell Physiol. 2003. PMID: 12388108 - Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase).
Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Kimura K, et al. Science. 1996 Jul 12;273(5272):245-8. doi: 10.1126/science.273.5272.245. Science. 1996. PMID: 8662509 - Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase.
Chihara K, Amano M, Nakamura N, Yano T, Shibata M, Tokui T, Ichikawa H, Ikebe R, Ikebe M, Kaibuchi K. Chihara K, et al. J Biol Chem. 1997 Oct 3;272(40):25121-7. doi: 10.1074/jbc.272.40.25121. J Biol Chem. 1997. PMID: 9312122 - The regulation of smooth muscle contractility by zipper-interacting protein kinase.
Ihara E, MacDonald JA. Ihara E, et al. Can J Physiol Pharmacol. 2007 Jan;85(1):79-87. doi: 10.1139/y06-103. Can J Physiol Pharmacol. 2007. PMID: 17487247 Review. - Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.
Fukata Y, Amano M, Kaibuchi K. Fukata Y, et al. Trends Pharmacol Sci. 2001 Jan;22(1):32-9. doi: 10.1016/s0165-6147(00)01596-0. Trends Pharmacol Sci. 2001. PMID: 11165670 Review.
Cited by
- SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants.
Wolff AW, Peine J, Höfler J, Zurek G, Hemker C, Lingor P. Wolff AW, et al. CNS Drugs. 2024 Apr;38(4):291-302. doi: 10.1007/s40263-024-01070-7. Epub 2024 Feb 28. CNS Drugs. 2024. PMID: 38416402 Free PMC article. Clinical Trial. - Pulses of RhoA signaling stimulate actin polymerization and flow in protrusions to drive collective cell migration.
Qian W, Yamaguchi N, Lis P, Cammer M, Knaut H. Qian W, et al. Curr Biol. 2024 Jan 22;34(2):245-259.e8. doi: 10.1016/j.cub.2023.11.044. Epub 2023 Dec 13. Curr Biol. 2024. PMID: 38096821 - Pulses of RhoA Signaling Stimulate Actin Polymerization and Flow in Protrusions to Drive Collective Cell Migration.
Qian W, Yamaguchi N, Lis P, Cammer M, Knaut H. Qian W, et al. bioRxiv [Preprint]. 2023 Oct 5:2023.10.03.560679. doi: 10.1101/2023.10.03.560679. bioRxiv. 2023. PMID: 37873192 Free PMC article. Updated. Preprint. - Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics.
Ruscetta VM, Seaton TJ, Shakeel A, Vasconcelos SNS, Viirre RD, Adler MJ, Olson MF. Ruscetta VM, et al. Cells. 2023 Feb 7;12(4):534. doi: 10.3390/cells12040534. Cells. 2023. PMID: 36831201 Free PMC article. Review. - Rho-Kinase/ROCK Phosphorylates PSD-93 Downstream of NMDARs to Orchestrate Synaptic Plasticity.
Hossen E, Funahashi Y, Faruk MO, Ahammad RU, Amano M, Yamada K, Kaibuchi K. Hossen E, et al. Int J Mol Sci. 2022 Dec 26;24(1):404. doi: 10.3390/ijms24010404. Int J Mol Sci. 2022. PMID: 36613848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous